Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Pharmaceutical Research|September 6, 2014
Mechanism of mucosal permeability enhancement of CriticalSorb® (Solutol® HS15) investigated in vitro in cell culturesSaif Shubber, Driton Vllasaliu, Cyril Rauch, et al.Biomaterials|July 24, 2012
Biomedical applications of amino acid-modified chitosans: a reviewLuca Casettari, Driton Vllasaliu, Jenny K W Lam, et al.Biomacromolecules|September 30, 2010
Effect of PEGylation on the toxicity and permeability enhancement of chitosanLuca Casettari, Driton Vllasaliu, Giuseppe Mantovani, et al.European Biophysics Journal : EBJ|August 28, 2003
Correlation of SEC/MALLS with ultracentrifuge and viscometric data for chitosansMonica Fee, Neil Errington, Kornelia Jumel, et al.Pharmaceutical Research|March 12, 2011
Surface characterisation of bioadhesive PLGA/chitosan microparticles produced by supercritical fluid technologyLuca Casettari, Enzo Castagnino, Snjezana Stolnik, et al.International Journal of Pharmaceutics|May 4, 2007
Intranasal delivery: physicochemical and therapeutic aspectsHenry R Costantino, Lisbeth Illum, Gordon Brandt, et al.International Journal of Pharmaceutics|April 25, 2012
Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative studyDriton Vllasaliu, Luca Casettari, Robyn Fowler, et al.International Journal of Pharmaceutics|August 24, 2010
Tight junction modulation by chitosan nanoparticles: comparison with chitosan solutionDriton Vllasaliu, Ruth Exposito-Harris, Angeles Heras, et al.Journal of Drug Targeting|June 18, 2009
Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epitheliumAlpesh Mistry, Sys Zoffmann Glud, Jørgen Kjems, et al.Pharmaceutical Research|February 23, 2008
Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat modelStuart T Charlton, Joanne Whetstone, Susan T Fayinka, et al.Pageof 4